Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.
about
Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestosThe metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidasesKey players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsCaffeic Acid phenethyl ester is a potential therapeutic agent for oral cancerClassification Framework and Chemical Biology of Tetracycline-Structure-Based DrugsMolecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.Significance of PELP1 in ER-negative breast cancer metastasisSignificance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancerGenetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.Effect of small interfering RNAs on matrix metalloproteinase 1 expression.Detection of gelatinase B activity in serum of gastric cancer patients.The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cellsClaudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression.Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Matrix metalloproteinase-7 expression in gastric carcinoma.Association between matrix metalloproteinase 1 -1607 1G>2G polymorphism and cancer risk: a meta-analysis including 19706 subjects.Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer.Matrix metalloproteinases and their inhibitors in gastric cancer.Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.Role of estrogen receptor signaling in breast cancer metastasis.Physiopathology of spine metastasis.Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasionExpression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomasDistribution of integrin cell adhesion molecules in endometrial cancer.Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis.Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis CCCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosisTyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes.Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer.Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stageCaffeic Acid phenethyl ester inhibits oral cancer cell metastasis by regulating matrix metalloproteinase-2 and the mitogen-activated protein kinase pathway.The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma.Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter.Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinomaExpression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpressionCross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo.
P2860
Q23923072-8E7477FA-A37D-41FC-9ED6-808DC731D361Q24675153-26CCC814-8CAE-4FC8-A054-52210EAF70EEQ26766065-FFEB408A-B5FE-47A7-A7F3-593C0FB8046DQ26822487-EED900C5-E6D6-4F9F-BF8F-013FAA357E56Q27024054-B91334DB-D9F2-4FFE-B401-0900EC2C2105Q27824854-8042B9DD-7309-4674-9FF2-AF3849097648Q28253038-229D043A-C99C-4D1C-8D18-0E365C9DD1C2Q28297295-74628831-1785-4477-AB26-D9E40315D47BQ33758871-7D24FEB5-DD1E-45DD-A29B-C4396DA93B52Q33783170-B4F0F9E1-FA5A-47A8-92A7-498987707E7BQ33829871-267915CE-48D6-4800-8B75-45E24C13A046Q33959078-1446F876-8667-4063-A375-65BAF35A0630Q33967794-67CD6CC2-6E07-437E-8C5A-77D414732FBFQ34327535-E216A6B5-743C-41D0-A237-792F0648EA70Q34410387-BD8C1CF9-75A3-4B2E-85CA-1653C2C58A22Q34415223-C45F9786-FDD8-4A8E-A22A-6D8F677339F4Q34700849-A767679B-C9B8-4769-A4C7-D01FA69CA7C5Q34997341-90E37A62-A767-4491-A572-F38DC0CA2D6AQ35353488-02146A00-C38B-4A8C-A2B4-FA0762C528C9Q35621600-3D9DF12E-ED7F-493A-838F-3B496EEA9E3CQ35684545-7BAD8A79-FC01-4707-A7CB-BAC20956A28EQ35692236-DD040819-3AF8-44A6-AE24-613F59B8F477Q35774094-901BCF48-6389-427A-9EEA-62744828A0D6Q35774146-893E9BAC-963A-45B8-BA02-6524072EDBC1Q35794894-2232F235-EBEB-4926-82A3-EA2D2C19D341Q35802700-8219D485-FEE3-48C5-BC77-07CD0F836BD4Q35810531-5B6A8888-85EE-4C65-B906-F903A5606D91Q35845411-9A9C655F-D297-447B-8A01-24DE4E1125AFQ36078608-BD71CD91-B628-4C99-84A2-757CCCEA164AQ36135770-BE67AB34-26EE-439E-8DD7-3A08416A79B3Q36244220-7AD06C5A-9834-4122-A8D1-3EB1DA760FA4Q36431093-C4F63A25-6F82-4FD3-9951-CA8AA4F0014CQ36504702-85894494-4708-47C6-A1B2-0A5B67FD96AFQ36604001-6CBA6F15-0CEE-423B-B699-EB301D73B8F8Q36617312-BA398927-23E6-46CC-A868-2B770B18E78FQ36617408-80A64965-209E-4F19-B574-AE6951041A03Q36617718-86F3B55C-3D72-4B37-AD7F-AA8E26199CA9Q36617818-ED709D0C-1323-4E8A-B914-9412C4919602Q36617875-A16401C3-45A3-4D30-A107-2070D951DD47Q36619650-2A60A349-B114-4A78-B36B-1C04BF52EAA6
P2860
Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Extracellular matrix 6: role o ...... tumor invasion and metastasis.
@en
type
label
Extracellular matrix 6: role o ...... tumor invasion and metastasis.
@en
prefLabel
Extracellular matrix 6: role o ...... tumor invasion and metastasis.
@en
P2093
P1433
P1476
Extracellular matrix 6: role o ...... tumor invasion and metastasis
@en
P2093
D E Kleiner
L A Liotta
W G Stetler-Stevenson
P304
P356
10.1096/FASEBJ.7.15.8262328
P407
P577
1993-12-01T00:00:00Z